We Can Medicines Co., Ltd. logo

We Can Medicines Co., Ltd. (6929)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
23. 10
+0.25
+1.0941%
NT$
- Market Cap
- P/E Ratio
0.4% Div Yield
9,000 Volume
- Eps
NT$ 22.85
Previous Close
Add Transaction
Day Range
22.2 23.3
Year Range
21.05 36.5
Want to track 6929 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

We Can Medicines Co., Ltd. (6929) Statistics

Valuation metrics

Market Cap -
Enterprise value 2.06B
Trailing P/E (ttm) -15.35
Forward P/E -
PEG ratio 154.09
Price/Sales (ttm) 0.34
Price/Book (mrq) 1.05
Enterprise Value/Revenue 0.64
Enterprise Value/EBITDA 7.94

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 7.03K
Average volume (90 days) 11.11K

Price summary

52-Week low 21.05
52-Week high 36.5
Beta -
50-Day moving average 23.13
200-Day moving average 27.09

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 26 Jun 2026
Ex-Dividend Date 10 Jun 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.02%
Operating margin -0.02%

Operational effectiveness

Return on assets -0.02%
Return on equity -0.07%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 71.44
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.56
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 5.48
Total debt (mrq) -
Total Debt/Equity (mrq) 1.2
Current ratio (mrq) 1.49%
Book value per share (mrq) 22.82

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -